GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » Long-Term Debt

KAPA (Kairos Pharma) Long-Term Debt : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kairos Pharma Long-Term Debt?

Kairos Pharma's Long-Term Debt for the quarter that ended in Sep. 2024 was $0.00 Mil.

Kairos Pharma's annual Long-Term Debt increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.58 Mil) but then declined from Dec. 2022 ($0.58 Mil) to Dec. 2023 ($0.00 Mil).

Kairos Pharma Long-Term Debt Historical Data

The historical data trend for Kairos Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kairos Pharma Long-Term Debt Chart

Kairos Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Long-Term Debt
- - 0.58 -

Kairos Pharma Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kairos Pharma  (AMEX:KAPA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Kairos Pharma Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Kairos Pharma's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Kairos Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kairos Pharma Ltd (AMEX:KAPA) » Definitions » Long-Term Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
2355 Westwood Boulevard, 139, Los Angeles, CA, USA, 90064
Website
https://kairospharma.com
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.